跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
吳 明順
副教授
,
消化內科
合聘副教授
,
國際醫學研究碩博士學位學程
合聘副教授
,
醫學教育暨人文學科
主治醫師
,
臺北市立萬芳醫院
成員
,
臺北醫學大學細胞治療與再生醫學研究中心
成員
,
臺北醫學大學消化醫學研究中心
https://orcid.org/0000-0002-5755-9062
電子郵件
mswu
tmu.edu
tw
h-index
1339
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1991 …
2024
每年研究成果
概覽
指紋
網路
專案
(11)
研究成果
(60)
資料集
(5)
類似的個人檔案
(6)
指紋
查看啟用 Ming-Shun Wu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Colon Cancer
100%
Phosphotransferase
95%
Nitric Oxide
79%
Reactive Oxygen Metabolite
75%
Colorectal Carcinoma
61%
Lipopolysaccharide
59%
Lipoteichoic Acid
59%
Evodiamine
59%
Heme Oxygenase 1
53%
Antioxidant
49%
Mouse
41%
Cytotoxicity
41%
Nonalcoholic Fatty Liver
40%
Ovary Cancer
39%
Antioxidant Capacity
39%
Bacteremia
39%
Fisetin
39%
Phosphotransferase Inhibitor
39%
Protein P53
37%
Protoporphyrin Cobalt
36%
Liver Cell Carcinoma
35%
Caspase 3
33%
Acetylcysteine
33%
Protein Kinases
32%
Infection
31%
anthra[1,9 Cd]pyrazol 6(2h) One
30%
Inflammation
29%
Sorafenib
27%
Acetic Acid Derivative
26%
Tetradium ruticarpum
26%
Cysteine
26%
Anti-Inflammatory Drug
26%
Phytochemical
24%
Nuclear Factor
24%
Alternative Complement Pathway C3 C5 Convertase
24%
Liver Cancer
24%
Disease
23%
Hydrogen Peroxide
23%
Retrospective Study
22%
Mitogen Activated Protein Kinase
22%
Normal Human
22%
Nocodazole
21%
Clinical Trial
21%
Paclitaxel
21%
Colon Carcinoma
21%
IC50
20%
Western Blot
20%
Anaplastic Thyroid Carcinoma
19%
Scutellaria baicalensis
19%
Mammalian Target of Rapamycin
19%
Medicine and Dentistry
Cancer Cell
59%
Programmed Cell Death
42%
Systematic Review
39%
Meta-Analysis
39%
Acute Pancreatitis
39%
Ovarian Cancer
39%
Percutaneous Endoscopic Gastrostomy
39%
Medicine
33%
Odds Ratio
26%
Acetylcysteine
25%
Reactive Oxygen Species
24%
Amino Terminal Sequence
24%
Phytochemical
24%
Retrospective Study
22%
Disease
21%
Esophagectomy
19%
Granulomatous Hepatitis
19%
Transforming Growth Factor Beta1
19%
Seroepidemiology
19%
Nose Feeding
19%
Tubular Adenoma
19%
Bacteriophage
19%
Postoperative Pain
19%
Pronase
19%
Campylobacter Coli
19%
Premedication
19%
Reflux Esophagitis
19%
Fucoxanthin
19%
Gastroesophageal Reflux
19%
Antiinfective Agent
19%
Auriculotherapy
19%
Gut
19%
Nanoparticle
19%
Liver Mitochondrion
19%
Analgesia
19%
Colorectal Cancer
19%
Anti-Inflammatory Drug
19%
Radiofrequency Ablation
19%
Wound Dressings
19%
Phosphotransferase
19%
Clinical Trial
19%
Rumex crispus
19%
Nilotinib
19%
Smooth Muscle Actin
19%
Vein Occlusion
19%
Transforming Growth Factor
19%
Controlled Release
19%
Nitric Oxide
19%
Spontaneous Bacterial Peritonitis
19%
Signet Ring Cell Carcinoma
19%
Biochemistry, Genetics and Molecular Biology
Cytotoxicity
65%
Cancer Cell
49%
P53
24%
Clinical Trial
23%
Acetylcysteine
21%
Mitochondrial Membrane Potential
21%
Fucoidan
19%
Leptin
19%
Retrospective Study
19%
Hsp90 Inhibitor
19%
Geldanamycin
19%
Radicicol
19%
Adiponectin
19%
Cysteine
19%
Antioxidant Activity
19%
Shotgun Sequencing
19%
Microbiome
19%
Rheum
19%
Pronase
19%
Phytochemical
19%
Oxygenase
19%
Tumor Antigen
19%
Metagenome
19%
Hemoglobin Blood Level
19%
Alanine Transaminase
19%
Calcium Acetate
19%
Caspase 3
19%
Molecular Weight
17%
Rumex crispus
17%
Colon
17%
Fusobacterium
11%
Prevalence
9%
Flow Cytometry
7%
Bifidobacterium longum
7%
Phylum
7%
Metaplasia
7%
Western Blot
7%
Ferritin Blood Level
6%
Anticancer
6%
Small Interfering RNA
5%
Caspase-9
5%
